All Articles

What a hundred tech firms admitting AI has already breached their own defences should mean for the NHS.

As Washington pushes old allies to rethink familiar partnerships, Mark Carney’s standoff with the United States may open an unexpected door for Europe and the NHS. The real prize is not simply lower tariffs. It is the chance to build new routes for patient access, staff, technology, market entry, clinical research and the cost of medicines.

Nvidia's record quarter shows how far the health service's AI ambitions now depend on infrastructure it neither owns nor controls.

The Care Quality Commission's latest inpatient survey shows a health service coping unevenly with pressure, and the unevenness has a shape.

The UCLH pituitary operation shows what real-time clinical AI can do, and how far the rules built for it still have to travel.

NHS England's refusal of Mid and South Essex's £94 million off-balance-sheet financing scheme reveals how tightly Whitehall now guards the boundary between public debt and private capital in a service starved of both.

Norfolk and Suffolk's advance to full mobilisation on its SystmOne rollout sits alongside trusts at earlier and more precarious stages of the same journey, exposing how unevenly digital maturity is spreading across the service just as its national overseer prepares to disappear.

A report built on three thousand complaints exposes commissioning failure just as the government prepares to decide what drives England's neurodevelopmental backlog.

Years of reluctance over Palantir's hold on NHS patient records coexist oddly with a quick deal to exchange UK expertise for Ukraine's military sensor data.

Implementation of a ministerially accepted 3 per cent uplift for senior NHS managers remains held back pending a review of how far performance-linked exclusions should extend.

How Scotland’s regional data centres prioritize American cloud giants over public healthcare infrastructure.

Ireland's structured approach to scaling digital pathways exposes the evidential gaps in England's own virtual ward expansion.

NHS England's retreat on patient data access exposes a gap between the ambitions of centralised health data and the unglamorous work of governing who gets to look at it.

How a near-affordable oral GLP-1, private-only until at least November, is likely to widen the gap between what patients can buy and what their local NHS will fund.

New community hubs and emergency departments mark an early domestic policy test for Yvette Cooper, while Somerset ICB's separate tender points to the smaller-scale procurement decisions now running alongside the national rollout.

The legal fight over sleep accuracy could have consequences far beyond consumers, including NHS observational studies, digital biomarkers and the future of wearable-led research.

As Experian promises to keep financial data isolated in AI tools, the NHS's recent privacy slip-ups show why tech architecture promises are getting harder for the public to trust.

TidalSense's £16 million raise lands the same week NHS England begins scoping the commercial architecture for AI-led diagnostics, and the gap between funding and delivery is where the real story sits.

Whistleblower claims at one of England's largest trusts suggest that regulatory intervention can coexist with a workplace where staff no longer trust the reporting system meant to protect patients.

Renewed theatre strikes at an enforcement-flagged trust raise questions about managerial consistency rather than clinical safety.